Synapse - Ferrata Storti Foundation

Results (355)

Integrated genomic analysis illustrates the central role of jak-stat pathway activation in myeloproliferative neoplasm pathogenesis

Meeting Abstract

Rampal, R.; Al-Shahrour, F.; Abdel-Wahab, O.; Patel, J.; Brunel, J. P.; Mermel, C.; Bass, A.; Pretz, J.; Ahn, J.; Hricik, T.; more...
Haematologica (2014)

Fulltext@MSK | Save

Requirement for CDK6 in MLL-rearranged acute myeloid leukemia

Meeting Abstract

Placke, T.; Faber, K.; Nonami, A.; Putwain, S.; Salih, H.; Heidel, F.; Kramer, A.; Root, D.; Barbie, D.; Armstrong, S.; more...
Haematologica (2014)

Fulltext@MSK | Save

Phase I trial of autologous Cd19-targeted car-modified T cells as consolidation after purine analog-based first-line therapy in patients with previously untreated cll

Meeting Abstract

Park, J. H.; Riviere, I.; Wang, X.; Bartido, S.; Sadelain, M.; Brentjens, R. J.
Haematologica (2014)

Fulltext@MSK | Save

Artesunate, an antimalarial drug displays preclinical activity in Flt3 mutated leukemia and synergises with arac

Meeting Abstract

Mony, U.; Hoya-Arias, R.; Ambati, S.; Pera, B.; Dogan, Y.; Peguero, E.; Shieh, J.H.; Moore, M.
Haematologica (2014)

Fulltext@MSK | Save

Genetic studies reveal Jak2 is not essential for platelet production

Meeting Abstract

Meyer, S. C.; Keller, M. D.; Woods, B. A.; LaFave, L. M.; Bastian, L.; Kleppe, M.; Bhagwat, N.; Marubayashi, S.; Levine, R. L.
Haematologica (2014)

Fulltext@MSK | Save

A phase Ib dose escalation trial of sar650984 (anti-cd-38 mab) in combination with lenalidomide and dexamethasone in relapsed/refractory multiple myeloma

Meeting Abstract

Martin, T.; Baz, R.; Benson, D.; Lendvai, N.; Vij, R.; Charpentier, E.; Hsu, K.
Haematologica (2014)

Fulltext@MSK | Save

Genetic correction of differently mobilized hematopoietic stem cells from patients with thalassemia and engraftment kinetics after xenotransplantation

Meeting Abstract

Karponi, G.; Papayanni, P.; Lederer, C. W.; Psatha, N.; Zervou, F.; Zogas, N.; Tsatalas, C.; Anagnostopoulos, A.; Sadelain, M.; Riviere, I.; more...
Haematologica (2014)

Fulltext@MSK | Save

Pre-treatment with idelalisib markedly reduces Rituximab infusion-related reactions and infusion interruptions in patients with CLL

Meeting Abstract

Hillmen, P.; Furman, R. R.; Coutre, S. E.; Sharman, J. P.; Pagel, J. M.; Barrientos, J. C.; Zelenetz, A. D.; Kipps, T. J.; Flinn, I.; Ghia, P.; more...
Haematologica (2014)

Fulltext@MSK | Save

Tyrosine kinase inhibitor (tki) switching: Experience from simplicity, a prospective observational study of chronic-phase chronic myeloid leukemia (cp-cml) patients in clinical practice